Tranexamic acid and vitamin K for bleeding in cirrhosis
Part of Digestive system clinical trials.
This trial tests if giving tranexamic acid and vitamin K by injection can help control bleeding from the upper digestive tract in people with liver cirrhosis. It may offer a way to stop bleeding more quickly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with liver cirrhosis.
- You have active bleeding from your upper digestive tract (such as your stomach or esophagus).
- You are not allergic to tranexamic acid or vitamin K injection.
- You do not have a condition called DIC (a blood clotting disorder).
- You are not pregnant or breastfeeding and have no end-stage kidney disease.
- You have not had a recent blood clot (thromboembolic event).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a protein called albumin along with standard care can improve outcomes for people with cirrhosis who are actively bleeding from swollen veins in their esophagus or stomach. If you qualify, you might receive extra albumin to help your body cope with the bleeding and possibly reduce complications.
This study tests whether a blood thinner called apixaban can safely prevent dangerous bleeding in people with cirrhosis (liver scarring) who have portal hypertension (high blood pressure in veins leading to the liver). The goal is to see if it reduces bleeding risk without causing excessive bleeding.
This trial tests a medication to help stop bleeding in the upper part of the stomach and esophagus. It may offer a new option for people with this urgent condition.
This trial tests a new oral blood thinner to prevent another bleeding episode in people with liver cirrhosis who have already had variceal bleeding and also have a clot in the portal vein. The goal is to see if it can safely reduce the risk of rebleeding.
This trial tests whether a pill (dabigatran) or a daily injection (enoxaparin) is better at preventing new blood clots in the liver vein for people with cirrhosis. Both are blood thinners, and the study wants to see which one is safer and more effective.
This trial studies bleeding problems in people with advanced liver cirrhosis or liver cancer. It aims to improve understanding of when blood transfusions or treatments are needed.
Hear when a new Upper Gastrointestinal Bleeding (UGIB) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.